Simulations Plus Uses Software to Design 12 Drug Candidates for Malaria Parasite | GenomeWeb

Simulations Plus said this week that it has used its suite of computational tools to create 12 drug-like molecules that could treat the parasite that causes malaria.

The company is currently seeking partners who are willing to synthesize and test the molecules. It has issued requests for quotes from chemical synthesis companies and contract research organizations to make the compounds and perform several tests on them to confirm its predictions.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.